Anyone who has followed the Flint water crisis for the past few years probably thinks of the post-industrial Michigan city as a place that can’t seem to catch a break. Five years after a state-appointed city manager switched the municipal water... Read more »
Despite the progress of gene therapy—a cutting edge medicine promising long-lasting effects from a single treatment—it remains a crude and limited tool. Startup Encoded Therapeutics has raised $104 million to join the race to expand gene therapy’s reach.
The South San... Read more »
A company that makes a mapping system to help doctors see high-resolution, 3D images of irregular heart rhythms in real time has raised $100 million in venture investment and a $70 million credit facility to fund its full-scale market launch.
Acutus... Read more »
Booster, an on-demand service that fills gas tanks for car owners while they shop at a mall or work at their office desks, announced Tuesday it has raised $56 million to expand into new territories.
San Mateo, CA-based Booster runs... Read more »
A special board of the US Patent and Trademark Office has reignited the long-running patent fight over who invented the groundbreaking CRISPR-Cas9 gene editing system.
Nearly a year ago, the matter seemed put to rest after a federal court upheld a... Read more »
Even as Uber, Lyft, and other high-profile initial public offerings underperformed out of the gate, the average share price of companies that have gone public in the US this year is up by almost 33 percent.
That’s according to data based... Read more »
Let’s catch up with the latest innovation news in Texas.
—Austin-based fragrance maker Phlur raised $7 million in a Series A round, the company announced. The investment was led by Symrise and included earlier investor Next Coast Ventures and new investor... Read more »
Everactive, a Bay Area startup, has raised $30 million in a Series C funding round. The investment was led by Future Fund with participation from Blue Bear Capital, ABB Technology Ventures, New Enterprise Associates, and Osage University... Read more »
[Updated, 10:11 am ET, see below.] Pharmaceutical giant AbbVie this morning agreed to acquire Allergan in a $63 billion deal meant to provide the pharmaceutical giant with enough revenue to brace for the loss of patent protection for the... Read more »
Conatus Pharmaceuticals said Monday that it would cut its staff by 40 percent and consider a sale or merger after a drug it was testing as a treatment for an increasingly common form of chronic liver disease failed to beat a... Read more »
To hear some people talk, you’d think the age of bipartisan action in Congress was a lost phenomenon of the distant past. But it’s not so, at least when it comes to certain issues. And no one knows it better than... Read more »
Youth. Charm. Fearlessness. Ruthless focus. These can be positive attributes in an entrepreneur, but in a more rational world, technology investors wouldn’t overvalue them. Risk capital would be allocated based mostly on evidence, data, progress towards milestones—in short, on proof.
In... Read more »
Editing human DNA has entered the public consciousness in a big way in recent years with its increasing use in laboratories—and, in recent news that shocked the scientific community, in embryos—of tools such as CRISPR-Cas9.
Locana, a gene therapy... Read more »